![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Publication history |
Reprints |
Permissions |
Cite this article as |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
REVIEW
Minerva Pediatrica 2020 April;72(2):116-22
DOI: 10.23736/S0026-4946.17.04823-X
Copyright © 2017 EDIZIONI MINERVA MEDICA
language: English
Recent perspectives of molecular aberrations in pediatric high-grade glioma
Zhengwei LI, Qingzeng SUN, Yingchun SHI ✉
Department of Pediatric Surgery, Xuzhou Children’s Hospital, Xuzhou Medical University, Xuzhou, China
Pediatric high-grade glioma (HGG), including diffuse intrinsic pontine glioma (DIPG) are highly aggressive tumors with no effective cures. Lack of understanding of the molecular biology of these tumors, in part due to lack of well-characterized pre-clinical models, is a great challenge in the development of novel therapies. Recent studies have shown that pediatric HGG short-term cell cultures retain many of the tumor characteristics in vivo and at present one of the best choices for in-vivo experimental studies. The present review article would put light on novel genetic and epigenetic changes in pediatric HGG that might, act as a gold standard potential biomarkers and/or therapeutic targets in near future.
KEY WORDS: Genetics; Biomarkers; Glioma